Recall: D-0016-2027

Class II - Potentially Harmful

Class IIClassification
2026-09-23Initiated
OngoingStatus
J&J INNOVATIVE MEDICINEFirm

Product

IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For Intravenous Infusion After Dilution, Rx only, Manufactured by: Janssen Biotech, Inc., Horsham, PA 19044. NDC: 57894-800-01

Reason

Presence of particulate matter.

Distribution

OH

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.